{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_topology","feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","contains":"claims, sources, anecdotes, question_graph slice","slug":"vip-glp1-gut","urls":{"read":"https://miscsubjects.com/api/articles/vip-glp1-gut/topology"},"how_to_use":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/vip-glp1-gut/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/vip-glp1-gut/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"graph_topology","name":"Cross-article graph","what":"Merged claims/sources across condition+stack slugs for one question.","urls":{"read":"https://miscsubjects.com/api/articles/vip-glp1-gut/graph-topology?question=..."}},{"id":"question_graph","name":"Question graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output).","urls":{"read":"https://miscsubjects.com/api/articles/vip-glp1-gut/question-graph","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/vip-glp1-gut/voxels","write":"https://miscsubjects.com/api/protocol/claim"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","why":"Every feature is auditable collective intelligence","how":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/vip-glp1-gut/topology"},"imessage":null,"router":null,"related":[{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"graph_topology","what":"Merged claims/sources across condition+stack slugs for one question."},{"id":"question_graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output)."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."}],"not_medical_advice":true},"slug":"vip-glp1-gut","title":"VIP Peptide and GLP-1 Agonist Gut Effects: Evidence on Motility and Repair Layers","register":"source_ledger","tags":["peptide","matrix"],"updated_at":"2026-07-17T02:43:24.048Z","body_excerpt":"## What's breaking down if you have GLP-1 gut damage / gastroparesis\n\nGLP-1 agonists slow gastric emptying as a known mechanism. If your gut motility slows too much, food stays in the stomach longer. This can lead to bloating, nausea, and in some cases symptoms that resemble gastroparesis. The enteric nervous system and smooth muscle layers handle coordinated contractions. When these signals weaken or inflammation rises, repair pathways may lag behind the ongoing stress from the drug. VIP acts as a signaling molecule in the gut wall. It supports smooth muscle relaxation and fluid secretion. If your issue traces to slowed motility or enteric nerve signaling, that layer sits upstream of symptom persistence.\n\n## Why VIP might help you\n\nYou are reading about GLP-1 gut damage / gastroparesis — what breaks down matters before any compound name.\n\nTherefore for you: If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain. Step 1: GLP-1 slows emptying via direct receptor effects on the stomach. Step 2: If enteric VIP pathways are under-active or stressed, adding VIP may support the relaxation phase of peristalsis in preclinical models. Step 3: This could allow better coordination of contractions over time rather than continued suppression. The logic stays at the immune/autonomic layer where VIP receptors sit on gut neurons and immune cells.\n\n## Why GLP-1 agonists (class) matters for you\n\nDrug: GLP-1 agonists (class). What it does: Metabolic benefit vs gut slowing / muscle loss tradeoffs at rapid weight loss. Therefore for you: This drug suppresses a motility signal. The suppression helps blood sugar control and appetite but trades off against normal gastric emptying speed. If your gastroparesis-like symptoms started or worsened on the drug, the tradeoff sits in the same autonomic/smooth muscle layer that VIP research targets. The metabolic support may reduce overall systemic load, yet the direct gut effect remains a known mechanism that does not promote motility repair.\n\n## How these fit together\n\nSingle-compound focus — VIP targets the immune / autonomic layer. GLP-1 agonists deliver metabolic change while adding a motility slowdown. If your profile includes both the drug load and motility symptoms, VIP sits at the repair side of the enteric signaling that the agonist can blunt. No multi-peptide stack is mapped here.\n\n## What the evidence actually shows\n\nPreclinical work shows VIP relaxes intestinal smooth muscle and supports secretion (mechanistic tier). VIP-null mice display altered glucose handling and changes in GLP-1 related pathways (preclinical). One 2024 study linked microbiome effects on small intestinal motility to VIP modulation (preclinical). No human trials of VIP for gastroparesis or GLP-1-induced gut slowing appear in the searched literature (human tier: absent). Gastroparesis reviews note delayed emptying as a core feature but do not test VIP as treatment (preclinical/mechanistic only for VIP angle).\n\n## What scientists say\n\nReviews place VIP in the glucagon/secretin family alongside GLP-1 and GLP-2. It functions as an inhibitory neurotransmitter in the gut, promoting relaxation. Animal data show VIP involvement in motility reflexes. Human data on VIP levels or supplementation in gastroparesis remain limited to indirect mentions in broader peptide physiology papers.\n\n## What people say on Reddit\n\nAnecdotal reports mention VIP in contexts of gut dysmotility and inflammatory conditions. One thread discusses VIP alongside other peptides for motility support. Separate posts describe BPC-157 experiences with gastroparesis symptoms but do not include VIP. No large volume of user reports specifically pairing VIP with GLP-1 side effects surfaced.\n\n## What people say on X\n\nPosts are mostly promotional for VIP research or list it among other peptides. One post references semaglutide side effects without linking to VIP. No detailed user outcome stories on VIP for GLP-","ranking":"safety-first (interaction_risk/limitations), then quote-gated effective_weight","claims":[{"id":"c3","text":"GLP-1 agonists slow gastric emptying as a direct mechanism.","tier":"mechanistic","weight":0.3,"section":"Why GLP-1 agonists (class) matters for you","slot":null,"interaction_risk":false,"status":"active","source_ids":["s3"],"source_status":"sourced","why_material":"Explains the tradeoff for readers experiencing gut slowing on the drug.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.3,"quote_gated":false},{"id":"c2","text":"No human trials of VIP for gastroparesis or GLP-1-induced gut slowing were identified.","tier":"human","weight":0.8,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s2"],"source_status":"sourced","why_material":"Clarifies the evidence gap for readers with this specific cross.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c1","text":"VIP relaxes intestinal smooth muscle and supports secretion in preclinical models.","tier":"mechanistic","weight":0.3,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes VIP's role in gut motility relevant to gastroparesis symptoms.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c4","text":"Reddit users discuss VIP in gut dysmotility contexts but lack specific GLP-1 gastroparesis pairings.","tier":"anecdotal","weight":0.3,"section":"What people say on Reddit","slot":null,"interaction_risk":false,"status":"active","source_ids":["s4"],"source_status":"sourced","why_material":"Separates anecdote from controlled data.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true}],"sources":[{"id":"s1","type":"pubmed","url":"https://www.sciencedirect.com/science/article/pii/S2352345X23002114","title":"Vasoactive Intestinal Polypeptide Plays a Key Role in the Regulation of Small Intestinal Motility","quote":"small intestinal motility, but not gastric emptying or colonic motility, is regulated by the microbiome through modulation of vasoactive intestinal polypeptide (VIP)","summary":"Preclinical study linking microbiome, VIP, and intestinal motility.","claim_ids":["c1"],"link_status":"http_403","quote_status":"unverified","hash":"a6408787cbea58e9f9cab4755c53278063288d69a27a4016cf3b64aa019fa368"},{"id":"s2","type":"review","url":"https://gut.bmj.com/content/early/2019/09/28/gutjnl-2019-318712","title":"Gastroparesis: a turning point in understanding and treatment","quote":"Gastroparesis is defined by delayed gastric emptying (GE) and symptoms of nausea, vomiting, bloating...","summary":"Clinical review on gastroparesis without VIP intervention data.","claim_ids":["c2"],"link_status":"http_403","quote_status":"unverified","hash":"eb20114a50b8efa03b140cb8dacf643f5b886d18209d01d85ec5123824a4801f"},{"id":"s3","type":"pubmed","url":"https://link.springer.com/article/10.1186/1471-230X-12-30","title":"Glucagon-like peptides 1 and 2 and vasoactive intestinal peptide","quote":"GI discomfort such as nausea, bloating, abdominal pain, constipation, diarrhea or delayed gastric emptying are common features","summary":"Discusses GLP-1 effects on gastric emptying.","claim_ids":["c3"],"link_status":"ok","quote_status":"verified","hash":"4b9380fbdd41f58c9b2950528540fa99bc1d92453d55d2d804023f7abe7d3409"},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/LAPeptidesGuide/comments/1u8cuai/bpc157_and_glp2_both_repair_the_gut_they_are/","title":"Discussion of peptides for gut issues","quote":"Individuals with chronic gut dysmotility, IBS, or inflammatory gut conditions where VIP's enteric nervous system regulatory activity addresses both motility and inflammation simultaneously","summary":"Anecdotal community mention of VIP for dysmotility.","claim_ids":["c4"],"link_status":"ok","quote_status":"unverified","hash":"69fb43dfa3c3b83e309f821123d7dd457cd6b7433bd4ac8e7516fb59b3eb27be"}],"anecdotal_sources":[{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/LAPeptidesGuide/comments/1u8cuai/bpc157_and_glp2_both_repair_the_gut_they_are/","title":"Discussion of peptides for gut issues","quote":"Individuals with chronic gut dysmotility, IBS, or inflammatory gut conditions where VIP's enteric nervous system regulatory activity addresses both motility and inflammation simultaneously","summary":"Anecdotal community mention of VIP for dysmotility.","claim_ids":["c4"],"link_status":"ok","quote_status":"unverified","hash":"69fb43dfa3c3b83e309f821123d7dd457cd6b7433bd4ac8e7516fb59b3eb27be"}],"scientific_sources":[{"id":"s1","type":"pubmed","url":"https://www.sciencedirect.com/science/article/pii/S2352345X23002114","title":"Vasoactive Intestinal Polypeptide Plays a Key Role in the Regulation of Small Intestinal Motility","quote":"small intestinal motility, but not gastric emptying or colonic motility, is regulated by the microbiome through modulation of vasoactive intestinal polypeptide (VIP)","summary":"Preclinical study linking microbiome, VIP, and intestinal motility.","claim_ids":["c1"],"link_status":"http_403","quote_status":"unverified","hash":"a6408787cbea58e9f9cab4755c53278063288d69a27a4016cf3b64aa019fa368"},{"id":"s2","type":"review","url":"https://gut.bmj.com/content/early/2019/09/28/gutjnl-2019-318712","title":"Gastroparesis: a turning point in understanding and treatment","quote":"Gastroparesis is defined by delayed gastric emptying (GE) and symptoms of nausea, vomiting, bloating...","summary":"Clinical review on gastroparesis without VIP intervention data.","claim_ids":["c2"],"link_status":"http_403","quote_status":"unverified","hash":"eb20114a50b8efa03b140cb8dacf643f5b886d18209d01d85ec5123824a4801f"},{"id":"s3","type":"pubmed","url":"https://link.springer.com/article/10.1186/1471-230X-12-30","title":"Glucagon-like peptides 1 and 2 and vasoactive intestinal peptide","quote":"GI discomfort such as nausea, bloating, abdominal pain, constipation, diarrhea or delayed gastric emptying are common features","summary":"Discusses GLP-1 effects on gastric emptying.","claim_ids":["c3"],"link_status":"ok","quote_status":"verified","hash":"4b9380fbdd41f58c9b2950528540fa99bc1d92453d55d2d804023f7abe7d3409"}],"user_reports":[],"related_articles":[],"question_graph":{"slug":"vip-glp1-gut","questions":[],"evidence":[],"edges":[],"counts":{"questions":0,"evidence":0,"edges":0}},"honesty":{"active_claims":4,"retracted_claims":0,"cut_claims":0,"challenges":0,"scrub_events":0,"note":"Retracted/cut claims stay on ledger but are excluded from ask unless ?include_inactive=1"},"counts":{"claims":4,"claims_total":4,"sources":4,"anecdotal":1,"scientific":3,"user_reports":0,"questions":0,"evidence_ingests":0}}